Immune protein shapes bone mass differently in female and male mice
Tracking mice lacking the immune protein interleukin-4 from 2 to 20 months revealed lower peak spongy bone mass in females and age-related bone loss in males.
Paper by Sadaf Dabeer, Ji Ae Lee, Daiana Weiss et al.

Our read
Mechanisms- Studied:
- Accepted, not yet published: experiments in male and female IL-4 knockout mice
- What changed:
- Females lacking IL-4 had lower peak spongy bone mass; males reached normal peaks, then lost bone with age
- The catch:
- Lifelong genetic changes do not measure effects of targeting the pathway later in life
- In the record:
- One of 83 papers on IL4 on record: 1 with results in people, 5 in animals.
Editor of record: Boris Djordjevic · AgingResearch.News
Male and female mice lacking the gene for interleukin-4, an immune signaling protein, were studied from 2 to 20 months of age in an animal experiment. The researchers examined trabecular bone, the spongy bone inside the skeleton.
Females failed to reach normal peak spongy bone mass but developed no additional deficit afterward. Males reached normal peak bone mass, then developed severe, progressive age-related loss of spongy bone. This loss was associated with increased bone breakdown and reduced bone formation. In a separate genetic experiment, the researchers deleted the receptor that receives interleukin-4 signals in the family of cells that includes bone-breaking cells. These mice also had reduced spongy bone mass in both sexes at 10 months.
Why it matters
Age-related bone loss makes understanding the immune system’s role in skeletal maintenance important. The authors suggest that disrupted interleukin-4 signaling may contribute to bone loss associated with immune dysfunction and identify it as a potential therapeutic target.
Caveats
Lifelong genetic changes in mice do not show whether targeting this signaling pathway later in life would preserve bone in people.
Where the evidence stands
The paper
Sadaf Dabeer, Ji Ae Lee, Daiana Weiss et al.
Frontiers in Endocrinology, Nov 16, 2026, CC BY, Accepted, not yet published


Comments
Be the first to comment.